Skip to main content

Table 1 IL-6 and IL-8 ascites levels in relation to different clinicopathological parameters

From: Prognostic significance of IL-6 and IL-8 ascites levels in ovarian cancer patients

  No of ascites tested (%) IL-6 mean pg/ml
(SEM)
IL-8 mean pg/ml
(SEM)
Total 39 6419 (1409) 1408 (437)
Stage    
I 9 (23) 4526 (3081) 1447 (997)
II 4 (10) 8893 (4719) 2738 (1786)
III 15 (39) 6550 (2521) 1181 (685)
IV 11 (28) 6514 (1869) 1119 (607)
Histopathology    
Serous 26 (67) 5209 (1484) 801 (339)
Mucinous 3 (8) 12641 (7227) 3375 (2596)
Mixed 7 (18) 8916 (4084) 2991 (1500)
Endometrioid 1 (2) 7896 (0) 463(0)
Other 2 (5) 1277 (583) 1268 (590)
Grading a    
1 4 (10) 3102 (1625) 228 (82)
2 10 (27) 8482 (3181) 842 (538)
3 20 (51) 5831 (1739) 1755 (661)
Residual tumor a    
≤ 2 cm 34 (87) 6286 (1487) 1555 (495)
> 2 cm 4 (10) 7457 (731) 378 (155)
Prior chemotherapy a    
Yes 4 (10) 444 (111) 430 (123)
No 34 (87) 6984 (1453)b 1972 (681)b
Serum CA125 a    
< 319 19 (49) 4063 (1841) 1372 (806)
> 319 19 (49) 4406 (1765) 1491 (788)
  1. a Data unavailable for grade (n = 4), residual tumor (n = 1), prior chemotherpay (n = 1), serum CA125 (n = 1)
  2. b IL-6, P = 0.0001; IL-8, P = 0.002